These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16679925)

  • 1. Successful report of reduced-intensity stem cell transplantation from unrelated umbilical cord blood in a girl with chronic active Epstein-Barr virus infection.
    Iguchi A; Kobayashi R; Sato TZ; Nakajima M; Kaneda M; Ariga T
    J Pediatr Hematol Oncol; 2006 Apr; 28(4):254-6. PubMed ID: 16679925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic active Epstein-Barr virus infection treated with reduced intensity stem cell transplantation].
    Sakata N; Sato E; Sawada A; Yasui M; Inoue M; Kawa K
    Rinsho Ketsueki; 2004 May; 45(5):393-6. PubMed ID: 15199749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic active Epstein-Barr virus infection with mosquito allergy successfully treated with reduced-intensity unrelated allogeneic bone marrow transplantation in a boy.
    Matsunaga T; Kurosawa H; Okuya M; Nakajima D; Hagisawa S; Sato Y; Fukushima K; Sugita K; Arisaka O
    Pediatr Transplant; 2009 Mar; 13(2):231-4. PubMed ID: 18627511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation.
    Ishimura M; Ohga S; Nomura A; Toubo T; Morihana E; Saito Y; Nishio H; Ide M; Takada H; Hara T
    Am J Hematol; 2005 Nov; 80(3):207-12. PubMed ID: 16247742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection.
    Kawa K; Sawada A; Sato M; Okamura T; Sakata N; Kondo O; Kimoto T; Yamada K; Tokimasa S; Yasui M; Inoue M
    Bone Marrow Transplant; 2011 Jan; 46(1):77-83. PubMed ID: 20498651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
    Uehara T; Nakaseko C; Hara S; Harima A; Ejiri M; Yokota A; Saito Y; Nishimura M
    Am J Hematol; 2004 Aug; 76(4):368-72. PubMed ID: 15282671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic active Epstein-Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantation.
    Taketani T; Kikuchi A; Inatomi J; Hanada R; Kawaguchi H; Ida K; Oh-Ishi T; Arai T; Kishimoto H; Yamamoto K
    Bone Marrow Transplant; 2002 Mar; 29(6):531-3. PubMed ID: 11960276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful umbilical cord blood transplantation from an unrelated donor for a patient with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Minegishi M; Ohashi Y; Kumaki S; Sasahara Y; Hayashi T; Asada H; Okuyama T; Hakozaki I; Sato T; Tsuchiya S
    Bone Marrow Transplant; 2001 Apr; 27(8):883-6. PubMed ID: 11477448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
    Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Allogeneic peripheral blood stem cell transplantation for a hepatitis B virus carrier with Epstein-Barr virus associated with hemophagocytic syndrome].
    Sakai R; Maruta A; Yamazaki E; Kamijo A; Taguchi J; Hyo R; Tanaka M; Fujimaki K; Nagao T; Yoshiba M; Ishigatsubo Y
    Rinsho Ketsueki; 2004 May; 45(5):397-401. PubMed ID: 15199750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CD34+ progenitor cell transplantation from HLA-mismatched donors to two patients with chronic active Epstein-Barr virus infection].
    Yasui M; Okamura T; Sakata N; Inoue M; Yagi K; Yoshimoto T; Mabuchi O; Sano M; Kawa K
    Rinsho Ketsueki; 2001 Nov; 42(11):1111-6. PubMed ID: 11808080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
    Yago K; Itoh M; Shimada H
    Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution.
    Nakai K; Mineishi S; Kami M; Saito T; Hori A; Kojima R; Imataki O; Hamaki T; Yoshihara S; Ohnishi M; Kim SW; Ando T; Fumitoh A; Kanda Y; Makimoto A; Tanosaki R; Kanai S; Heike Y; Ohnishi T; Kawano Y; Wakasugi H; Takaue Y
    Transplantation; 2003 Jun; 75(12):2135-43. PubMed ID: 12829926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.
    Ohga S; Kanaya Y; Maki H; Takada H; Ohshima K; Kanda M; Nomura A; Suminoe A; Matsuzaki A; Hara T
    Bone Marrow Transplant; 2000 Jan; 25(2):209-12. PubMed ID: 10673683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful reduced-intensity stem cell transplantation with cord blood for a poor-prognosis adult with refractory chronic active epstein-barr virus infection.
    Nakagawa M; Hashino S; Takahata M; Kawamura T; Fujisawa F; Kahata K; Kondo T; Imamura M; Ando S; Asaka M;
    Int J Hematol; 2007 Jun; 85(5):443-5. PubMed ID: 17562623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients.
    Del Toro G; Satwani P; Harrison L; Cheung YK; Brigid Bradley M; George D; Yamashiro DJ; Garvin J; Skerrett D; Bessmertny O; Wolownik K; Wischhover C; van de Ven C; Cairo MS
    Bone Marrow Transplant; 2004 Mar; 33(6):613-22. PubMed ID: 14730337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unrelated cord blood transplant experience by the pediatric blood and marrow transplant consortium.
    Yu LC; Wall DA; Sandler E; Chan KW; Grayson G; Kletzel M
    Pediatr Hematol Oncol; 2001 Jun; 18(4):235-45. PubMed ID: 11400647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of natural killer (NK) cell leukemia following a long-standing chronic active Epstein-Barr virus (CAEBV) infection with allogeneic bone marrow transplantation.
    Ebihara Y; Manabe A; Tanaka R; Yoshimasu T; Ishikawa K; Iseki T; Hayakawa J; Maeda M; Asano S; Tsuji K
    Bone Marrow Transplant; 2003 Jun; 31(12):1169-71. PubMed ID: 12796798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience.
    Buchholz S; Dammann E; Koenecke Ch; Stadler M; Franzke A; Blasczyk R; Bremer M; Krauter J; Hertenstein B; Ganser A; Eder M
    Ann Hematol; 2008 Jul; 87(7):551-6. PubMed ID: 18386010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.